Atlas Trials

Probiotics Enhance the Treatment of PD-1 Inhibitors in Patients With Liver Cancer

Clinical trial NCT05032014 · UNKNOWN

Trial details

NCT number
NCT05032014
Sponsor
Jiangxi Provincial Cancer Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Liver Cancer
Start date
2021-11-19
Primary completion
2022-12-27
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.